0.070000000 CAD
0
0%
Last update Nov 17, 12:16 PM EST
Market closed
Day range
0.070000000
0.070000000
Previous close
0.070000000
Open
0.070000000
Access this stock data via API
Subscribe
Nirvana Life Sciences Inc.
0.07
0
0%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 0 115.2K 91.5K 320.8K
Selling general and admin 138.4K 389.8K 767.3K 369.3K
Other operating expenses 227.5K 220.7K 300.0K 77.3K
Operating income -365.9K -744.0K -1.3M -1.2M
Non operating interest income
Income 0 54 12.3K
Expense 0 665 8.4K 0
Other income expense -128.7K -232.7K -4.5M
Pretax income -365.9K -873.4K -1.5M -5.7M
Tax provision
Net income -365.9K -873.4K -1.5M -5.7M
Basic EPS -0.1 -0.2 0.0 -0.2
Diluted EPS -0.1 -0.2 0.0 -0.2
Basic average shares 4.8M 4.7M 33.9M 36.5M
Diluted average shares 4.8M 4.7M 33.9M 36.5M
EBITDA -365.9K -725.7K -1.2M -1.1M
Net income from continuing op. -365.9K -873.4K -1.5M -5.7M
Minority interests 3 1.5K 4.2K 2.5K
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 10 hours 27 minutes

21:32
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/Toronto timezone (EST, UTC-05:00).